购物车
您的购物车当前为空
Relzomostat is a MetAP2 inhibitor, specifically targeting methionine aminopeptidase 2. It holds potential in research concerning obesity, type 2 diabetes, and other conditions associated with obesity.

Relzomostat is a MetAP2 inhibitor, specifically targeting methionine aminopeptidase 2. It holds potential in research concerning obesity, type 2 diabetes, and other conditions associated with obesity.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 6-8周 |
| 产品描述 | Relzomostat is a MetAP2 inhibitor, specifically targeting methionine aminopeptidase 2. It holds potential in research concerning obesity, type 2 diabetes, and other conditions associated with obesity. |
| 分子量 | 470.558 |
| 分子式 | C24H36F2N2O5 |
| CAS No. | 2081078-92-2 |
| Smiles | [H][C@@]1([#6@H](-[#8]-[#6])-[#6@@H](-[#6]-[#6][C@]11[#6]-[#8]1)-[#8]-[#6](=O)-[#7]-1-[#6]C2([#6]-[#7](-[#6]-[#6](F)F)-[#6]2)[#6]-1)[C@@]1([#6])[#8]-[#6@@H]1-[#6]\[#6]=[#6](\[#6])-[#6] |
| 密度 | 1.27 g/cm3 (Predicted) |
| 存储 |
对于不同动物的给药剂量换算,您也可以参考 更多